Tucson, AZ, United States of America

Ken Hance


Average Co-Inventor Count = 23.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
3 patents (USPTO):

Title: Ken Hance: Innovator in Microorganism Identification and Antimicrobial Testing

Introduction

Ken Hance, based in Tucson, AZ, has made significant contributions to the field of microbiology through his inventive capabilities. With a remarkable portfolio that includes three patents, Ken is poised as a key figure in the development of automated systems for microorganism identification and antibiotic susceptibility testing.

Latest Patents

Among his latest innovations, Ken's patents address an "Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing." This sophisticated system comprises a reagent cartridge, a reagent stage, a pipettor assembly, an optical detection system, and a controller. It is engineered to dynamically adjust motor idle torque to manage heat load and incorporates a fast focus process to accurately ascertain the focus position of individual microorganisms. Additionally, the system enhances the quantification of viable microorganisms using dynamic dilution and supports the growth of these organisms in tailored media, enabling rapid and precise antimicrobial susceptibility testing.

Career Highlights

Throughout his career, Ken has contributed extensively to the industry, notably at Accelerate Diagnostics, Inc. and Accelerate Giagnostics, Inc. His innovative mindset and problem-solving skills have led to the conception of technologies that promise to revolutionize how microorganisms and antibiotic susceptibility are handled in clinical settings.

Collaborations

In his journey, Ken has collaborated with other talented professionals, including William L. Richards and Austin Micheil Ashby. These partnerships have been crucial in advancing the projects and achieving significant breakthroughs in their respective fields.

Conclusion

Ken Hance continues to drive innovation within the microbiology domain with his cutting-edge patents and collaborative efforts. His work not only enhances the efficiency of microorganism identification but also elevates the standards of antimicrobial susceptibility testing, ultimately contributing to improved healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…